SSCA
TMO icon

South Shore Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

South Shore Capital Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$313K Hold
624
– – 0.21% 107
2026
Q1 		$307K Buy
+624
New +$339K 0.22% 101

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

South Shore Capital Advisors's TMO Position: Q2 2026 in Review

South Shore Capital Advisors held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 624 shares worth $313K. The position accounts for 0.21% of the portfolio, ranked #107.

South Shore Capital Advisors first reported a position in TMO in Q1 2026 and has held it in 2 quarters since. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • South Shore Capital Advisors held 624 shares of Thermo Fisher Scientific worth $313K as of Q2 2026.
  • South Shore Capital Advisors left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 0.21% of South Shore Capital Advisors's portfolio in Q2 2026, its #107 holding.
  • South Shore Capital Advisors first reported a position in Thermo Fisher Scientific in Q1 2026 and has held it in 2 quarters since.
  • 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on South Shore Capital Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.